HER-2/HER-1 vaccine (Ohio State University)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHER-2/HER-1 vaccine (Ohio State University)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulatorsReceptor protein-tyrosine kinase erbB-2 modulators
TargetsEpidermal growth factor receptor erbB1Receptor protein-tyrosine kinase erbB-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Ohio State University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A